Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

PHASE3CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

August 9, 2020

Study Completion Date

September 9, 2020

Conditions
Gastric CancerObesity
Interventions
DRUG

Sugammadex Sodium

"1. INDICATIONS AND USAGE BRIDION® is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. BRIDION (sugammadex) injection is a sterile, clear, colorless to slightly yellow-brown, non-pyrogenic aqueous solution intended for intravenous infusion.~2. DOSAGE AND ADMINISTRATION BRIDION (sugammadex) injection, for intravenous use, should be administered by trained healthcare providers familiar with the use, actions, characteristics, and complications of neuromuscular blocking agents (NMBA) and neuromuscular block reversal agents."

Trial Locations (1)

02841

Korea University Anam Hospital, Seoul

All Listed Sponsors
lead

Korea University Anam Hospital

OTHER

NCT03196791 - Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient | Biotech Hunter | Biotech Hunter